Literature DB >> 24717282

Use of the retrograde approach for preserving the distal bifurcation after antegrade crossing of a right coronary artery chronic total occlusion.

Anna Kotsia1, George Christopoulos, Emmanouil S Brilakis.   

Abstract

Percutaneous coronary intervention (PCI) of a chronic total occlusion (CTO) can be challenging when a bifurcation is present at the distal cap. We describe a case of combined use of the antegrade and retrograde approach for preserving a distal cap bifurcation during CTO PCI.

Entities:  

Mesh:

Year:  2014        PMID: 24717282

Source DB:  PubMed          Journal:  J Invasive Cardiol        ISSN: 1042-3931            Impact factor:   2.022


  5 in total

1.  The impact of percutaneous coronary intervention of chronic total occlusions on left ventricular function and clinical outcomes.

Authors:  Georgios E Christakopoulos; Muhammad Nauman J Tarar; Emmanouil S Brilakis
Journal:  J Thorac Dis       Date:  2015-07       Impact factor: 2.895

2.  A New Occluding Balloon-Facilitated Reversed Guidewire Technique in Successful Percutaneous Coronary Intervention for the Right Coronary Artery Chronic Total Occlusion Involving Distal Bifurcation.

Authors:  Kuan-Liang Liu; Chi-Jen Chang
Journal:  Acta Cardiol Sin       Date:  2021-05       Impact factor: 2.672

Review 3.  Approach to CTO Intervention: Overview of Techniques.

Authors:  Aris Karatasakis; Barbara Anna Danek; Dimitri Karmpaliotis; Khaldoon Alaswad; Minh Vo; Mauro Carlino; Mitul P Patel; Stéphane Rinfret; Emmanouil S Brilakis
Journal:  Curr Treat Options Cardiovasc Med       Date:  2017-01

4.  The Hybrid Approach to Intervention of Chronic Total Occlusions

Authors:  Bavana V Rangan; Anna Kotsia; George Christopoulos; James Spratt; Stephane Rinfret; Subhash Banerjee; Emmanouil S Brilakis
Journal:  Curr Cardiol Rev       Date:  2015-11-06

Review 5.  Complications of chronic total occlusion percutaneous coronary intervention.

Authors:  J Karacsonyi; E Vemmou; I D Nikolakopoulos; I Ungi; B V Rangan; E S Brilakis
Journal:  Neth Heart J       Date:  2020-10-27       Impact factor: 2.380

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.